COPSLIE License Plate Case

Here is the decision in the New Hampshire COPSLIE license plate case,  Montenegro v. N.H. Div. of Motor Vehicles (N.H. May 7, 2014).

David Montenegro may have won his case, but doesn’t he fear that cops will illegally pull him over in violation of his Fourth Amendment rights merely because they dislike his license plate, only to lie about their reasons in court?

He should have gotten a license plate like this:

10301600_10152784595393332_1278822019671256801_n

Radical Law Center Featured on “Lowering the Bar”

Attorney: “The Training I Received at Hustler Was Extremely Helpful” in Law School

Susannah Breslin, who is a contributor at Forbes.com, has posted her interview with Dan Kapelovitz, who is currently a criminal-law attorney but previously worked at Hustler magazine. See How A Porn Magazine Editor Became A Criminal Law Attorney,” Forbes.com (Apr. 17, 2003).

According to this, that magazine has articles in it, and Kapelovitz worked as an editor/writer of said articles. He says he frequently wrote about criminal-law topics, and ultimately decided to go to law school. “It turned out that I loved law school,” he says, “and the writing and editing training I received at Hustler was extremely helpful.”

You should read the whole interview, which has many great quotes in it. I will just borrow one more:

What’s the difference between being a porn magazine editor and being a criminal law attorney?

Not much…. [I]n both jobs, you spend hours and hours researching and writing something that very few people are going to actually read.

Don’t Become a Hostage in an L.A. County Jail

If you are ever visiting someone in the Los Angeles County jail system, try to not to become a hostage. Pursuant to the California Code of Regulations, “hostages will not be recognized for bargaining purposes” during attempted escapes by inmates. (See Section 3304, California Code of Regulations, Title 15, Division 3, Chapter 1.)

In other words, you are doomed.

 http://www.cdcr.ca.gov/Regulations/Adult_Operations/docs/Title15-2013.pdf

“Driving While Weird”

by Dan Kapelovitz

On April 4, 2007, Don Bolles, the once and current drummer of the Germs, was arrested for possession of a controlled substance. The substance? Dr. Bronner’s Soap. Peppermint, to be exact. Bolles, 50, was driving himself and his 21-year-old girlfriend, Cat Scandal, through the clean streets of Newport Beach to an Alcoholics Anonymous meeting when he was pulled over for a faulty tail-light.

When the cops discovered a bottle of organic liquid soap, they separated Don and his girlfriend and asked them independently what the product was. They both said it was soap. Unconvinced, the police performed a field test on the substance, and it tested positive for the so-called date-rape drug GHB (gamma-Hydroxybutyric acid).

Many people who know Bolles and his personal hygiene habits (or lack thereof) couldn’t believe that he actual used soap, much less carried it on his person at all times.

“I don’t bathe that often,” Bolles admits, “but when I do, I use Dr. Bronner’s. I’ve been using it for 35 years. I brush my teeth with it, I do my laundry it, and wash my face with it.”

Bolles spent four days in various Orange County detention facilities.

“I got thrown into a cell with a guy who smelled like the most evil barf,” recalls Bolles. “He was a porcupine of evil barf smell, just spewing these barbs of evil barf.”

Bolles was also charged with contempt of court and for violating a protective/stay away order.

Bolles claims that he and Cat have an “amicable restraining order” where the two can see each other if they so please. “In this post-O. J. world, everyone has to sign a restraining order,” says Bolles. “We have a full-contact restraining order. It’s full-service. We get to live together, get to have sodomy of all different sorts and varieties. We can do any kind of hideous evil sex act to each other–animals, things alive and dead of all descriptions and some with none, and certain nuns too. We just can’t annoy, harass or date-rape each other with GHB.”

The contempt of court charge was based on the felony drug charge itself; if Don actually had been possessing GHB, then he would have been in violation of his probation.

Nora Keyes, a band member with Don in the Fancy Space People, organized a web campaign via MySpace to raise bail, and Giddle Partridge, a former Bolles bandmate, called Dr. Bronner’s Magic Soaps headquarters and contacted Michael Bronner, Vice-President and grandson of the original Dr. Bronner. Bronner offered to post bail, but by that time, enough small donations had been raised to bail Bolles out of jail.

Bronner then offered to pay Bolles’s legal fees and hired Bolles an attorney.

Of the field tests, a lawyer working on the case said, “I don’t think a test that is that inaccurate should be used by the police, who are taking people’s liberties away.”

When the authorities tested the soap in a real lab, it tested negative for GHB. An Orange County DA spokesperson has said that all charges have been dropped, but according Laschley-Haynes, the DA wants to test the soap yet another time.

Bolles believes he was pulled over and subsequently searched for “driving while weird.”

Laschley-Haynes agrees: “If you look out of the norm, especially if you are somewhere in Orange County, you get profiled, unfortunately. If it were me in my suit, driving my decent car, I highly doubt they ever would have tested soap in my purse. The sad thing is that things like this happen all of the time. His case just happened to get some attention because of his musical background.”

Attention it has gotten. Bolles’s arrest started a mini-media frenzy. Don was quoted extensively in the press as crediting the soap with giving him the complexion of a 15-year-old girl, an assertion mocked by Jimmy Kimmel on national television.

“He is actually a pretty good spokesperson,” says David Bronner, President of Dr. Bronner’s.

Bolles visited Dr. Bronner’s distribution center in Escondido, where he learned that Internet sales have skyrocketed since his arrest. He was asked by Dr. Bronner’s employees to sign bottles of the soap. “They were in a real lather about it,” punned Bolles.

The Bronners bought drug-test kits of the kind used on Bolles’s soap and tried it on various other soaps, including Neutrogena and Tom’s of Maine, which also tested positive for GHB.

Either something’s amiss with these police field drug-testing kits or someone is trying to date-rape America by dosing our soap supply.

There is talk of a possible civil suit, and Dr. Bronner’s is considering sponsoring some of Don’s artistic endeavors. Don may actually profit from his misfortune. But when it is suggested that this may be the best thing that ever happened to him, Bolles responds, “If this is the best thing that ever happened to me, I’ve had a pretty shitty life.”

If you or someone you care about has been arrested for possession of soap, call the Radical Law Center today!

“Superfluity does not vitiate” and other maxims found in the Cal. Civ. Code

The California Civil Code enumerates the following maxims of jurisprudence:*

3510. When the reason of a rule ceases, so should the rule itself.

3511. Where the reason is the same, the rule should be the same.

3512. One must not change his purpose to the injury of another.

3513. Any one may waive the advantage of a law intended solely for his benefit. But a law established for a public reason cannot be contravened by a private agreement.

3514. One must so use his own rights as not to infringe upon the rights of another.

3515. He who consents to an act is not wronged by it.

3516. Acquiescence in error takes away the right of objecting to it.

3517. No one can take advantage of his own wrong.

3518. He who has fraudulently dispossessed himself of a thing may be treated as if he still had possession.

3519. He who can and does not forbid that which is done on his behalf, is deemed to have bidden it.

3520. No one should suffer by the act of another.

3521. He who takes the benefit must bear the burden.

3522. One who grants a thing is presumed to grant also whatever is essential to its use.

3523. For every wrong there is a remedy.

3524. Between those who are equally in the right, or equally in the
wrong, the law does not interpose.

3525. Between rights otherwise equal, the earliest is preferred.

3526. No man is responsible for that which no man can control.

3527. The law helps the vigilant, before those who sleep on their rights.

3528. The law respects form less than substance.

3529. That which ought to have been done is to be regarded as done, in favor of him to whom, and against him from whom, performance is due.

3530. That which does not appear to exist is to be regarded as if it did not exist.

3531. The law never requires impossibilities.

3532. The law neither does nor requires idle acts.

3533. The law disregards trifles.

3534. Particular expressions qualify those which are general.

3535. Contemporaneous exposition is in general the best.

3536. The greater contains the less.

3537. Superfluity does not vitiate.

3538. That is certain which can be made certain.

3539. Time does not confirm a void act.

3540. The incident follows the principal, and not the principal the incident.

3541. An interpretation which gives effect is preferred to one which makes void.

3542. Interpretation must be reasonable.

3543. Where one of two innocent persons must suffer by the act of a
third, he, by whose negligence it happened, must be the sufferer.

3545. Private transactions are fair and regular.

3546. Things happen according to the ordinary course of nature and the ordinary habits of life.

3547. A thing continues to exist as long as is usual with things of that nature.

3548. The law has been obeyed.

*WARNING: The maxims set forth above “are intended not to qualify any of the foregoing provisions of this Code, but to aid in their just application.” Cal. Civ. Code § 3509.

 

How the California legislature defines “controlled substances”

The California Health and Safety Code defines “controlled substances” thusly:

11053. The controlled substances listed or to be listed in the schedules in this chapter are included by whatever official, common, usual, chemical, or trade name designated.

11054. (a) The controlled substances listed in this section are included in Schedule I.

(b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of those isomers, esters, ethers, and salts is possible within the specific chemical designation:

  • (1) Acetylmethadol.
  • (2) Allylprodine.
  • (3) Alphacetylmethadol (except levoalphacetylmethadol, also known as levo-alpha- acetylmethadol, levomethadyl acetate, or LAAM).
  • (4) Alphameprodine.
  • (5) Alphamethadol.
  • (6) Benzethidine.
  • (7) Betacetylmethadol.
  • (8) Betameprodine.
  • (9) Betamethadol.
  • (10) Betaprodine.
  • (11) Clonitazene.
  • (12) Dextromoramide.
  • (13) Diampromide.
  • (14) Diethylthiambutene.
  • (15) Difenoxin.
  • (16) Dimenoxadol.
  • (17) Dimepheptanol.
  • (18) Dimethylthiambutene.
  • (19) Dioxaphetyl butyrate.
  • (20) Dipipanone.
  • (21) Ethylmethylthiambutene.
  • (22) Etonitazene.
  • (23) Etoxeridine.
  • (24) Furethidine.
  • (25) Hydroxypethidine.
  • (26) Ketobemidone.
  • (27) Levomoramide.
  • (28) Levophenacylmorphan.
  • (29) Morpheridine.
  • (30) Noracymethadol.
  • (31) Norlevorphanol.
  • (32) Normethadone.
  • (33) Norpipanone.
  • (34) Phenadoxone.
  • (35) Phenampromide.
  • (36) Phenomorphan.
  • (37) Phenoperidine.
  • (38) Piritramide.
  • (39) Proheptazine.
  • (40) Properidine.
  • (41) Propiram.
  • (42) Racemoramide.
  • (43) Tilidine.
  • (44) Trimeperidine.
  • (45) Any substance which contains any quantity of acetylfentanyl (N-[1-phenethyl-4-piperidinyl] acetanilide) or a derivative thereof.
  • (46) Any substance which contains any quantity of the thiophene analog of acetylfentanyl (N-[1-[2-(2-thienyl)ethyl]-4-piperidinyl] acetanilide) or a derivative thereof.
  • (47) 1-Methyl-4-Phenyl-4-Propionoxypiperidine (MPPP).
  • (48) 1-(2-Phenethyl)-4-Phenyl-4-Acetyloxypiperidine (PEPAP).

(c) Opium derivatives. Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of those salts, isomers, and salts of isomers is possible within the specific chemical designation:

  • (1) Acetorphine.
  • (2) Acetyldihydrocodeine.
  • (3) Benzylmorphine.
  • (4) Codeine methylbromide.
  • (5) Codeine-N-Oxide.
  • (6) Cyprenorphine.
  • (7) Desomorphine.
  • (8) Dihydromorphine.
  • (9) Drotebanol.
  • (10) Etorphine (except hydrochloride salt).
  • (11) Heroin.
  • (12) Hydromorphinol.
  • (13) Methyldesorphine.
  • (14) Methyldihydromorphine.
  • (15) Morphine methylbromide.
  • (16) Morphine methylsulfonate.
  • (17) Morphine-N-Oxide.
  • (18) Myrophine.
  • (19) Nicocodeine.
  • (20) Nicomorphine.
  • (21) Normorphine.
  • (22) Pholcodine.
  • (23) Thebacon.

(d) Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers whenever the existence of those salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this subdivision only, the term “isomer” includes the optical, position, and geometric isomers):

  • (1) 4-bromo-2,5-dimethoxy-amphetamine–Some trade or other names: 4-bromo-2,5-dimethoxy-alpha-methylphenethylamine; 4-bromo-2,5 DMA.
  • (2) 2,5-dimethoxyamphetamine–Some trade or other names: 2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA.
  • (3) 4-methoxyamphetamine–Some trade or other names: 4-methoxy-alpha-methylphenethylamine, paramethoxyamphetamine, PMA.
  • (4) 5-methoxy-3,4-methylenedioxy-amphetamine.
  • (5) 4-methyl-2,5-dimethoxy-amphetamine–Some trade or other names: 4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; “DOM”; and “STP.”
  • (6) 3,4-methylenedioxy amphetamine.
  • (7) 3,4,5-trimethoxy amphetamine.
  • (8) Bufotenine–Some trade or other names: 3- (beta-dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5 indolol; N,N-dimethylserolonin, 5-hydroxy-N,N-dimethyltryptamine; mappine.
  • (9) Diethyltryptamine–Some trade or other names: N,N-Diethyltryptamine; DET.
  • (10) Dimethyltryptamine–Some trade or other names: DMT.
  • (11) Ibogaine–Some trade or other names: 7-Ethyl-6,6beta, 7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1′,2′:1,2] azepino [5,4-b] indole; Tabernantheiboga.
  • (12) Lysergic acid diethylamide.
  • (13) Marijuana.
  • (14) Mescaline.
  • (15) Peyote–Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of the plant, and every compound, manufacture, salts, derivative, mixture, or preparation of the plant, its seeds or extracts (interprets 21 U.S.C. Sec. 812(c), Schedule 1(c)(12)).
  • (16) N-ethyl-3-piperidyl benzilate.
  • (17) N-methyl-3-piperidyl benzilate.
  • (18) Psilocybin.
  • (19) Psilocyn.
  • (20) Tetrahydrocannabinols. Synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as the following: delta 1 cis or trans tetrahydrocannabinol, and their optical isomers; delta 6 cis or trans tetrahydrocannabinol, and their optical isomers; delta 3,4 cis or trans tetrahydrocannabinol, and its optical isomers.    (Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered).
  • (21) Ethylamine analog of phencyclidine–Some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE.
  • (22) Pyrrolidine analog of phencyclidine–Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCP, PHP.
  • (23) Thiophene analog of phencyclidine–Some trade or other names: 1-[1-(2 thienyl)-cyclohexyl]-piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP.

(e) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of those salts, isomers, and salts of isomers is possible within the specific chemical designation:

  • (1) Mecloqualone.
  • (2) Methaqualone.
  • (3) Gamma hydroxybutyric acid (also known by other names such as GHB; gamma hydroxy butyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate), including its immediate precursors, isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, including, but not limited to, gammabutyrolactone, for which an application has not been approved under Section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 355).

(f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its isomers:

  • (1) Cocaine base.
  • (2) Fenethylline, including its salts.
  • (3) N-Ethylamphetamine, including its salts.

11055. (a) The controlled substances listed in this section are included in Schedule II.

(b) Any of the following substances, except those narcotic drugs listed in other schedules, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by combination of extraction and chemical synthesis:

  • (1) Opium, opiate, and any salt, compound, derivative, or preparation of opium or opiate, with the exception of naloxone hydrochloride (N-allyl-14-hydroxy-nordihydromorphinone hydrochloride), but including the following:(2) Any salt, compound, isomer, or derivative, whether natural or synthetic, of the substances referred to in paragraph (1), but not including the isoquinoline alkaloids of opium.
    • (A) Raw opium.
    • (B) Opium extracts.
    • (C) Opium fluid extracts.
    • (D) Powdered opium.
    • (E) Granulated opium.
    • (F) Tincture of opium.
    • (G) Codeine.
    • (H) Ethylmorphine.
    • (I) Hydrocodone.
    • (J) Hydromorphone.
    • (K) Metopon.
    • (L) Morphine.
    • (M) Oxycodone.
    • (N) Oxymorphone.
    • (O) Thebaine.
  • (3) Opium poppy and poppy straw.
  • (4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, but not including decocainized coca leaves or extractions which do not contain cocaine or ecgonine.
  • (5) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy).
  • (6) Cocaine, except as specified in Section 11054.
  • (7) Ecgonine, whether natural or synthetic, or any salt, isomer, derivative, or preparation thereof.

(c) Opiates. Unless specifically excepted or unless in another schedule, any of the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of those isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan and levopropoxyphene excepted:

  • (1) Alfentanyl.
  • (2) Alphaprodine.
  • (3) Anileridine.
  • (4) Bezitramide.
  • (5) Bulk dextropropoxyphene (nondosage forms).
  • (6) Dihydrocodeine.
  • (7) Diphenoxylate.
  • (8) Fentanyl.
  • (9) Isomethadone.
  • (10) Levoalphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM. This substance is authorized for the treatment of narcotic addicts under federal law (see Part 291 (commencing with Section 291.501) and Part 1308 (commencing with Section 1308.01) of Title 21 of the Code of Federal Regulations).
  • (11) Levomethorphan.
  • (12) Levorphanol.
  • (13) Metazocine.
  • (14) Methadone.
  • (15) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane.
  • (16) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid.
  • (17) Pethidine (meperidine).
  • (18) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine.
  • (19) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate.
  • (20) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid.
  • (21) Phenazocine.
  • (22) Piminodine.
  • (23) Racemethorphan.
  • (24) Racemorphan.
  • (25) Sufentanyl.

(d) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:

  • (1) Amphetamine, its salts, optical isomers, and salts of its optical isomers.
  • (2) Methamphetamine, its salts, isomers, and salts of its isomers.
  • (3) Dimethylamphetamine (N,N-dimethylamphetamine), its salts, isomers, and salts of its isomers.
  • (4) N-Ethylmethamphetamine (N-ethyl, N-methylamphetamine), its salts, isomers, and salts of its isomers.
  • (5) Phenmetrazine and its salts.
  • (6) Methylphenidate.
  • (7) Khat, which includes all parts of the plant classified botanically as Catha Edulis, whether growing or not, the seeds thereof, any extract from any part of the plant, and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or extracts.
  • (8) Cathinone (also known as alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone).

(e) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of those salts, isomers, and salts of isomers is possible within the specific chemical designation:

  • (1) Amobarbital.
  • (2) Pentobarbital.
  • (3) Phencyclidines, including the following:(4) Secobarbital.
    • (A) 1-(1-phenylcyclohexyl) piperidine (PCP).
    • (B) 1-(1-phenylcyclohexyl) morpholine (PCM).
    • (C) Any analog of phencyclidine which is added by the Attorney General by regulation pursuant to this paragraph.    The Attorney General, or his or her designee, may, by rule or regulation, add additional analogs of phencyclidine to those enumerated in this paragraph after notice, posting, and hearing pursuant to Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. The Attorney General shall, in the calendar year of the regular session of the Legislature in which the rule or regulation is adopted, submit a draft of a proposed bill to each house of the Legislature which would incorporate the analogs into this code. No rule or regulation shall remain in effect beyond January 1 after the calendar year of the regular session in which the draft of the proposed bill is submitted to each house. However, if the draft of the proposed bill is submitted during a recess of the Legislature exceeding 45 calendar days, the rule or regulation shall be effective until January 1 after the next calendar year.
  • (5) Glutethimide.

(f) Immediate precursors. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:

  • (1) Immediate precursor to amphetamine and methamphetamine:
    • (A) Phenylacetone. Some trade or other names: phenyl-2 propanone; P2P; benzyl methyl ketone; methyl benzyl ketone.
  • (2) Immediate precursors to phencyclidine (PCP):
    • (A) 1-phenylcyclohexylamine.
    • (B) 1-piperidinocyclohexane carbonitrile (PCC).

11056. (a) The controlled substances listed in this section are included in Schedule III.

(b) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of those isomers whenever the existence of those salts, isomers, and salts of isomers is possible within the specific chemical designation:

  • (1) Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the Code of Federal Regulations, and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances.
  • (2) Benzphetamine.
  • (3) Chlorphentermine.
  • (4) Clortermine.
  • (5) Mazindol.
  • (6) Phendimetrazine.

(c) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:

  • (1) Any compound, mixture, or preparation containing any of the following:
    • (A) Amobarbital
    • (B) Secobarbital
    • (C) Pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.
  • (2) Any suppository dosage form containing any of the following:(3) Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof.
    • (A) Amobarbital
    • (B) Secobarbital
    • (C) Pentobarbital or any salt of any of these drugs and approved by the federal Food and Drug Administration for marketing only as a suppository.
  • (4) Chlorhexadol.
  • (5) Lysergic acid.
  • (6) Lysergic acid amide.
  • (7) Methyprylon.
  • (8) Sulfondiethylmethane.
  • (9) Sulfonethylmethane.
  • (10) Sulfonmethane.
  • (11) Gamma hydroxybutyric acid, and its salts, isomers and salts of isomers, contained in a drug product for which an application has been approved under Section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 355).

(d) Nalorphine.

(e) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

  • (1) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium.
  • (2) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
  • (3) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium.
  • (4) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts. Additionally, oral liquid preparations of dihydrocodeinone containing the above specified amounts may not contain as its nonnarcotic ingredients two or more antihistamines in combination with each other.
  • (5) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts.
  • (6) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
  • (7) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
  • (8) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.

(f) Anabolic steroids and chorionic gonadotropin. Any material, compound, mixture, or preparation containing chorionic gonadotropin or an anabolic steroid (excluding anabolic steroid products listed in the “Table of Exempt Anabolic Steroid Products” (Section 1308.34 of Title 21 of the Code of Federal Regulations), as exempt from the federal Controlled Substances Act (Section 801 and following of Title 21 of the United States Code)), including, but not limited to, the following:

  • (1) Androisoxazole.
  • (2) Androstenediol.
  • (3) Bolandiol.
  • (4) Bolasterone.
  • (5) Boldenone.
  • (6) Chlormethandienone.
  • (7) Clostebol.
  • (8) Dihydromesterone.
  • (9) Ethylestrenol.
  • (10) Fluoxymesterone.
  • (11) Formyldienolone.
  • (12) 4-Hydroxy-19-nortestosterone.
  • (13) Mesterolone.
  • (14) Methandriol.
  • (15) Methandrostenolone.
  • (16) Methenolone.
  • (17) 17-Methyltestosterone.
  • (18) Methyltrienolone.
  • (19) Nandrolone.
  • (20) Norbolethone.
  • (21) Norethandrolone.
  • (22) Normethandrolone.
  • (23) Oxandrolone.
  • (24) Oxymestrone.
  • (25) Oxymetholone.
  • (26) Quinbolone.
  • (27) Stanolone.
  • (28) Stanozolol.
  • (29) Stenbolone.
  • (30) Testosterone.
  • (31) Trenbolone.
  • (32) Chorionic Gonadotropin (HGC).

(g) Ketamine. Any material, compound, mixture, or preparation containing ketamine.

(h) Hallucinogenic substances. Any of the following hallucinogenic substances: dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a drug product approved by the federal Food and Drug Administration.

11057. (a) The controlled substances listed in this section are included in Schedule IV.

(b) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

(c) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

  • (1) Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.
  • (2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane).
  • (3) Butorphanol.

(d) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of those salts, isomers, and salts of isomers is possible within the specific chemical designation:

  • (1) Alprazolam.
  • (2) Barbital.
  • (3) Chloral betaine.
  • (4) Chloral hydrate.
  • (5) Chlordiazepoxide.
  • (6) Clobazam.
  • (7) Clonazepam.
  • (8) Clorazepate.
  • (9) Diazepam.
  • (10) Estazolam.
  • (11) Ethchlorvynol.
  • (12) Ethinamate.
  • (13) Flunitrazepam.
  • (14) Flurazepam.
  • (15) Halazepam.
  • (16) Lorazepam.
  • (17) Mebutamate.
  • (18) Meprobamate.
  • (19) Methohexital.
  • (20) Methylphenobarbital (Mephobarbital).
  • (21) Midazolam.
  • (22) Nitrazepam.
  • (23) Oxazepam.
  • (24) Paraldehyde.
  • (25) Petrichoral.
  • (26) Phenobarbital.
  • (27) Prazepam.
  • (28) Quazepam.
  • (29) Temazepam.
  • (30) Triazolam.
  • (31) Zaleplon.
  • (32) Zolpidem.

(e) Fenfluramine. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of those isomers, whenever the existence of those salts, isomers, and salts of isomers is possible:

  • (1) Fenfluramine.

(f) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of those isomers is possible within the specific chemical designation:

  • (1) Diethylpropion.
  • (2) Mazindol.
  • (3) Modafinil.
  • (4) Phentermine.
  • (5) Pemoline (including organometallic complexes and chelates thereof).
  • (6) Pipradrol.
  • (7) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
  • (8) Cathine ((+)-norpseudoephedrine).

(g) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of pentazocine, including its salts.

11058. (a) The controlled substances listed in this section are included in Schedule V.

(b) Schedule V shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

(c) Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below, which shall include one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by narcotic drugs alone:

  • (1) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams.
  • (2) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams.
  • (3) Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams.
  • (4) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit.
  • (5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams.
  • (6) Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.

(d) Buprenorphine.

This list is current as of October 13, 2013, and is subject to change.  The legislature may add  drugs to this list as they are discovered (likely) or subtract drugs from this list as they are legalized (not so likely).